Collegium Pharmaceutical Inc (COLL) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $44.22
• Market Cap: $1.45B
• P/E Ratio: 28.07
• EPS: $1.63
• 52-Week High: $50.79
• 52-Week Low: $23.23

Market Sentiment

Collegium Pharmaceutical Inc currently has a Neutral sentiment score of 0.04.

About Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. is a specialized pharmaceutical company based in Stoughton, Massachusetts, dedicated to the development and commercialization of innovative pain management solutions. The company boasts a diverse portfolio of unique drug formulations that target various pain-related conditions, showcasing its commitment to meeting the complex needs of patients. With a strong focus on enhancing the quality of care in pain management, Collegium is strategically positioned to lead ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Collegium Pharmaceutical Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does COLL pay dividends?

Collegium Pharmaceutical Inc (COLL) does not currently pay a regular dividend.

What is COLL's P/E ratio?

Collegium Pharmaceutical Inc has a price-to-earnings (P/E) ratio of 28.07.

What is COLL's market cap?

Collegium Pharmaceutical Inc (COLL) has a market capitalization of $1.45B with a current stock price of $44.22.